Velicept Therapeutics
Latest round
- Series B
Last raised
- Oct 2018
Total raised
- $36M
Investors
- 6
About Velicept Therapeutics
Founded in 2015 and based in Pennsylvania, US, Velicept Therapeutics, Inc. is a clinical-stage pharmaceutical company that develops Solabegron, a therapeutic drug for treating urological and gastrointestinal disorders such as overactive bladder (OAB) and irritable bowel syndrome (IBS).
Who invested in Velicept Therapeutics
6 investors across 2 rounds
See all investors in Velicept Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Velicept Therapeutics
Who invested in Velicept Therapeutics?
Velicept Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Velicept Therapeutics raised?
Velicept Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Velicept Therapeutics last raise money?
Velicept Therapeutics's most recent round on record is a Series B, in Oct 2018.
What does Velicept Therapeutics do?
Founded in 2015 and based in Pennsylvania, US, Velicept Therapeutics, Inc.
Where is Velicept Therapeutics headquartered?
Velicept Therapeutics is headquartered in Wayne, US.
Which VCs invest in companies like Velicept Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Velicept Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Velicept Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.